Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

SPOT ON

New European guideline on lowering cholesterol: as low as possible?

NEW ON THE MARKET

Sublingual immunotherapy of tree pollen allergy with ITULAZAX

THERAPY FROM A CRITICAL VIEWPOINT

Tranexamic acid (e.g. CYKLOKAPRON) after traumatic brain injury?

a-t READERS QUESTIONS AND COMMENTS

Sacubitril plus valsartan (ENTRESTO) for initial treatment of heart failure?

50 YEARS arznei-telegramm

50 years drug information – start of the a-t in turbulent times

arznei-telegramm from within – who we are and how we work

Drugs through the ages – from small molecules to complex biologics

Not optimal yet – trials and approval decisions

Drug risks – recognise early and prevent

A matter of price – how much may a drug cost?

Belittling and misleading advertising – a permanent threat

Drug quality – further positive or worsening?

IN BRIEF

Antiphospholipid syndrome – once again increased risk of thromboembolism with rivaroxaban (XARELTO)

Flurbiprofen lozenges in France available only on prescription

Policies on conflicts of interest are missing at medical schools
free

CURRENT ADR NETWORK REPORT

Neuropsychiatric adverse effects with montelucast (SINGULAIR, generics)

SIDE EFFECTS

Tofacitinib (XELJANZ): caution in case of increased risk of thromboembolism

Vaginal rings for contraception – generics break more often

e a-t ON THE INTERNET

Mail order – potency drugs contain overdoses in some cases

Supplier does not want a black triangle for CARIBAN

Methocarbamol (ORTOTON, generics) against back pain – addendum: erroneous publication corrected

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles